A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE.
Wenjia ZhuRu JiaQiao YangYuejuan ChengHong ZhaoChunmei BaiJianming XuShaobo YaoLi HuoPublished in: European journal of nuclear medicine and molecular imaging (2021)
ClinicalTrials.gov identifier: NCT04318561.